Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMC Cancer|August 14, 2010
LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cellsJung-Young Shin, Jeong-Oh Kim, Suk Kyeong Lee, et al.
Anticancer Research|October 1, 2021
Synergistic Antitumor Effect of Taxanes and CDK4/6 Inhibitor in Lung Cancer Cells and Mice Harboring KRAS MutationsKyoung-Hwa Son, Min-Young Kim, Jung-Young Shin, et al.
Cancers|October 26, 2024
Enhancing Intrapleural Hyperthermic Chemotherapy for Lung Cancer: Insights from 3D and PDX ModelsJung Young Shin, Mi Ran Lee, Kyung Ah Choi, et al.
Cancer Research and Treatment|October 16, 2010
Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicitySeong-Ae Yoon, Jung Ran Choi, Jeong-Oh Kim, et al.
American Journal of Cancer Research|March 10, 2023
FOXA2 and STAT5A regulate oncogenic activity of KIF5B-RET fusionMi-Ran Lee, Jung-Young Shin, Min-Young Kim, et al.
Cancer Biology & Therapy|June 25, 2013
A CDK4/6 inhibitor enhances cytotoxicity of paclitaxel in lung adenocarcinoma cells harboring mutant KRAS as well as wild-type KRASXiang-Hua Zhang, Ying Cheng, Jung-Young Shin, et al.
Cancers|December 3, 2020
A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer PatientsJung-Young Shin, Jeong-Oh Kim, Mi-Ran Lee, et al.
BMC Cancer|November 4, 2020
Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinomaMin-Young Kim, Jung-Young Shin, Jeong-Oh Kim, et al.
Cancer Letters|March 22, 2012
Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutationsXiang-Hua Zhang, Jung-Young Shin, Jeong-Oh Kim, et al.
Cancer Research and Treatment|February 5, 2015
Genetic Variations of Drug Transporters Can Influence on Drug Response in Patients Treated with Docetaxel ChemotherapyJung Ran Choi, Jeong-Oh Kim, Dae Ryong Kang, et al.
Pageof 2